Project

SAKK HD 21

Ongoing - recruitment closed · 2017 until 2099

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2017
End Date
2099
Financing
SAKK
Labels
lymphoma
Brief description/objective

Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; comparison of 6 cycles of escalated BEACOPP with 6 cycles of BrECADD.